These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Virus plaque assay and enumeration of effector cells in mixed lymphocyte cultures. Bloom BR; Kano S; Howe ML Transplant Proc; 1973 Dec; 5(4):1705-9. PubMed ID: 4359723 [No Abstract] [Full Text] [Related]
46. Age related changes in the in vitro immune response: increased suppressor activity in immature and aged mice. DeKruyff RH; Kim YT; Siskind GW; Weksler ME J Immunol; 1980 Jul; 125(1):142-7. PubMed ID: 6445918 [No Abstract] [Full Text] [Related]
47. Developmental aspects of delayed hypersensitivity. Berkel AI Boll Ist Sieroter Milan; 1974; 53(1):suppl:147-51. PubMed ID: 4277433 [No Abstract] [Full Text] [Related]
48. The nonspecific helper effect of mixed lymphocyte reactions on the induction of T cell-mediated immunity in vitro. Altman A; Cohen IR Eur J Immunol; 1974 Aug; 4(8):577-80. PubMed ID: 4278331 [No Abstract] [Full Text] [Related]
49. The function of autoreactive T cells in B-cell activation. Finnegan A; Needleman BW; Hodes RJ Year Immunol; 1985; ():25-38. PubMed ID: 2953143 [No Abstract] [Full Text] [Related]
50. Immunosuppression associated with SJL/J murine lymphoma. I. Suppression of cell-mediated immune responses after tumor transplantation. Kumar RK; Lykke AW; Penny R J Natl Cancer Inst; 1981 Dec; 67(6):1269-75. PubMed ID: 6458725 [TBL] [Abstract][Full Text] [Related]
51. Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia. Good RA Birth Defects Orig Artic Ser; 1975; 11(1):377-9. PubMed ID: 238679 [No Abstract] [Full Text] [Related]
52. [Immunological status of newly detected patients with destructive pulmonary tuberculosis]. Khomenko AG; Averbakh MM; Rudoĭ NM; Litvinov VI; Gergert VIa Probl Tuberk; 1979 Apr; (4):13-7. PubMed ID: 312495 [No Abstract] [Full Text] [Related]
53. Lymphocyte responsiveness to mitogens and quantitation of T and B lymphocytes in canine malignant lymphoma. Dutta SK; Novilla MN; Bumgardner MK; Ingling A Am J Vet Res; 1978 Mar; 39(3):455-8. PubMed ID: 305738 [TBL] [Abstract][Full Text] [Related]
54. Posttransplant evaluation of T- and B-cell function. Suciu-Foca N; Woodward K; Reed E; Khan R; Godfrey M; Hardy M; Reemtsma K Transplant Proc; 1981 Sep; 13(3):1584-8. PubMed ID: 6458129 [No Abstract] [Full Text] [Related]
55. Development of the fetal immune system. Siegel I; Gleicher N Prog Clin Biol Res; 1981; 70():31-40. PubMed ID: 6458824 [No Abstract] [Full Text] [Related]
56. Immunological studies of autoimmune thyroid disorders: abnormalities in the inducer T cell subset and proliferative responses to autologous and allogeneic stimulation. Fournier C; Chen H; Leger A; Charreire J Clin Exp Immunol; 1983 Nov; 54(2):539-46. PubMed ID: 6228354 [TBL] [Abstract][Full Text] [Related]
57. Cell-mediated immunity in aged mice: an underlying lesion in IL 2 synthesis. Thoman ML; Weigle WO J Immunol; 1982 May; 128(5):2358-61. PubMed ID: 6460821 [TBL] [Abstract][Full Text] [Related]
59. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases. Lukes RJ; Parker JW; Taylor CR; Tindle BH; Cramer AD; Lincoln TL Semin Hematol; 1978 Oct; 15(4):322-51. PubMed ID: 366759 [No Abstract] [Full Text] [Related]
60. Lymphocyte stimulation in patients with lymphoma cutis. Mekori T; Robinson E; Haim S Oncology; 1974; 30(4):273-7. PubMed ID: 4459741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]